Skip to main content
Fig. 7 | BMC Cancer

Fig. 7

From: Identification of HM13 as a prognostic indicator and a predictive biomarker for immunotherapy in hepatocellular carcinoma

Fig. 7

Relationship between HM13 and immune checkpoint genes and the potential of HM13 in predicting immunotherapeutic response in HCC. A Oncoplots of top 10 mutated genes in high- and low-HM13 expression subgroups. B Correlation and difference analysis of HM13 expression and TMB. C-D Correlation and difference analysis of HM13 and PD1 and CTLA4 expression. E HM13 expression in different anti-PD1 and antiCTLA4 responses of patients from the IMvigor210 cohort

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us